Janssen Pharmaceutica, N.V. et al v. Mylan Pharmaceuticals, Inc. et al
||Janssen Pharmaceutica, N.V., Janssen Sciences Ireland UC, Gilead Sciences Ireland UC and Gilead Sciences, Inc.
||Mylan Pharmaceuticals, Inc. and Mylan Inc.
||August 31, 2015
||US District Court for the District of Delaware
||Sue L. Robinson
|Nature of Suit:
|Cause of Action:
|Jury Demanded By:
Access additional case information on PACER
Available Case Documents
The following documents for this case are available for you to view or download:
|January 6, 2017
MEMORANDUM OPINION providing claim construction for a disputed term in U.S. Patent No. 8,101,629. Within five days the parties shall submit a proposed order consistent with this Memorandum Opinion. Signed by Judge Richard G. Andrews on 1/6/2017. (nms)
|September 29, 2016
MEMORANDUM ORDER ADOPTING 96 REPORT AND RECOMMENDATIONS ; denying 40 Motion to Dismiss ; denying 57 Motion to Strike and Sever. Signed by Judge Sue L. Robinson on 9/29/2016. (nmfn)
Use the links below to access additional information about this case on the US Court's PACER system.
A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?